@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M0TFM153-6
  skos:prefLabel "Atropines"@fr, "Atropine Derivatives"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-MQNLK1DG-2 .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KD3ZGZ4K-4
  skos:prefLabel "Bronchodilator Agents"@en, "Bronchodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KTK6KVK9-4
  skos:prefLabel "Antagonistes cholinergiques"@fr, "Cholinergic Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HFWV2449-0
  skos:prefLabel "Association de bromure d'ipratropium et de salbutamol"@fr, "Albuterol, Ipratropium Drug Combination"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MQNLK1DG-2 .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MQNLK1DG-2
  mesh:allowableQualifier jvr:-CB30NGKB-3, jvr:-D0F21513-5, jvr:-L6C0XPHT-4, jvr:-H7K65Q8S-Z, jvr:-NKM836P1-M, jvr:-G4R176S9-J, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-G30ZJ446-J, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-SBNWSM1T-R, jvr:-M63HSDM7-1, jvr:-S0CS1X5R-5, jvr:-THHNVC7V-3, jvr:-NB0XHT3S-N, jvr:-XV06LPML-W, jvr:-R3QWLHRG-V, jvr:-R0ZCQ8X6-J ;
  skos:altLabel "22254-24-6 (bromide)"@fr, "22254-24-6 (bromide)"@en, "GR88G0I6UL"@en, "GR88G0I6UL"@fr, "VJV4X1P2Z1"@fr, "VJV4X1P2Z1"@en, "60205-81-4 (Ipratropium)"@fr, "60205-81-4 (Ipratropium)"@en, "J697UZ2A9J"@fr, "J697UZ2A9J"@en, "58073-59-9 (bromide, (endo,anti)-isomer)"@fr, "58073-59-9 (bromide, (endo,anti)-isomer)"@en, "(endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane"@en, "N-Isopropylatropine"@en, "60251-88-9 (bromide, (exo,syn)-isomer)"@fr, "60251-88-9 (bromide, (exo,syn)-isomer)"@en, "24358-20-1 (bromide, endo-isomer)"@fr, "24358-20-1 (bromide, endo-isomer)"@en, "8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, (endo,syn)-(+-)-"@en, "8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, (endo,syn)-(+-)-"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D009241> ;
  skos:hiddenLabel "Ipratropium Bromide, (exo,syn)-Isomer"@en, "Itrop"@en, "Sch1178"@fr, "Sch1000"@fr, "Ipratropium Bromide"@en, "Sch-1178"@fr, "Sch-1178"@en, "Ipratropium Bromide, (endo,anti)-Isomer"@en, "Atrovent"@en, "Sch-1000"@en, "Sch-1000"@fr, "Ipratropium Bromide Anhydrous"@en, "Bromure d'ipratropium anhydre"@fr, "Ipratropium Bromide Monohydrate"@en, "Ipratropium Bromide, endo-Isomer"@en, "Bromure d'ipratropium"@fr ;
  mesh:pharmacologicalAction jvr:-KTK6KVK9-4, jvr:-KD3ZGZ4K-4 ;
  skos:definition "A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic."@en ;
  skos:inScheme jvr: ;
  dc:created "1974-11-19"^^xsd:date ;
  skos:narrower jvr:-HFWV2449-0 ;
  a mesh:Descriptor, skos:Concept ;
  dc:established "1991-01-01"^^xsd:date ;
  skos:broader jvr:-M0TFM153-6 ;
  skos:prefLabel "Ipratropium"@en, "Ipratropium"@fr ;
  dc:modified "2018-02-27"^^xsd:date .

